-
1
-
-
2342466734
-
Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030
-
Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diab Care 2004, 27:1047-1053.
-
(2004)
Diab Care
, vol.27
, pp. 1047-1053
-
-
Wild, S.1
Roglic, G.2
Green, A.3
Sicree, R.4
King, H.5
-
2
-
-
0031975069
-
The effects of improved glycemic control on complications in type 2 diabetes
-
DOI 10.1001/archinte.158.2.134
-
Gaster B, Hirsch IB: The effects of improved glycemic control on complications in type 2 diabetes. Arch Intern Med 1998, 158:134-140. (Pubitemid 28049506)
-
(1998)
Archives of Internal Medicine
, vol.158
, Issue.2
, pp. 134-140
-
-
Gaster, B.1
Hirch, I.B.2
-
3
-
-
41149095006
-
Treatment of diabetic neuropathy and neuropathic pain: How far have we come?
-
Ziegler D: Treatment of diabetic neuropathy and neuropathic pain: how far have we come? Diab Care 2008, 31(Suppl 2):S255-61.
-
(2008)
Diab Care
, vol.31
, Issue.SUPPL. 2
-
-
Ziegler, D.1
-
4
-
-
0027403979
-
Nerve function and its determinants in patients with newly-diagnosed Type 2 (non-insulin-dependent) diabetes mellitus and in control subjects - A 5-year follow up
-
DOI 10.1007/BF00399096
-
Lehtinen JM, Niskanen L, Hyvonen K, Siitonen O, Uusitupa M: Nerve function and its determinants in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus and in control subjects-a 5-year follow-up. Diabetologia 1993, 36:68-72. (Pubitemid 23018338)
-
(1993)
Diabetologia
, vol.36
, Issue.1
, pp. 68-72
-
-
Lehtinen, J.M.1
Niskanen, L.2
Hyvonen, K.3
Siitonen, O.4
Uusitupa, M.5
-
5
-
-
0031972613
-
Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (NIDDM)
-
DOI 10.1002/(SICI)1097-4598(199801)21:1<72::AID-MUS10>3.0.CO;2-2
-
Cohen JA, Jeffers BW, Faldut D, Marcoux M, Schrier RW: Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (NIDDM). Muscle Nerve 1998, 21:72-80. (Pubitemid 28041683)
-
(1998)
Muscle and Nerve
, vol.21
, Issue.1
, pp. 72-80
-
-
Cohen, J.A.1
Jeffers, B.W.2
Faldut, D.3
Marcoux, M.4
Schrier, R.W.5
-
6
-
-
35148833511
-
Subclinical neuropathy among diabetes control and complications trial participants without diagnosable neuropathy at trial completion: Possible predictors of incident neuropathy?
-
Albers JW, Herman WH, Pop-Busui R, et al.: Subclinical neuropathy among diabetes control and complications trial participants without diagnosable neuropathy at trial completion: Possible predictors of incident neuropathy? Diab Care 2007, 30:2613-2618.
-
(2007)
Diab Care
, vol.30
, pp. 2613-2618
-
-
Albers, J.W.1
Herman, W.H.2
Pop-Busui, R.3
-
7
-
-
77950511412
-
Executive summary: Standards of medical care in diabetes-2010
-
Executive summary: Standards of medical care in diabetes-2010. Diab Care 2010, 33 Suppl 1:S4-10.
-
(2010)
Diab Care
, vol.33
, Issue.SUPPL. 1
-
-
-
8
-
-
75149180515
-
Standards of medical care in diabetes-2010
-
American Diabetes Association
-
American Diabetes Association: Standards of medical care in diabetes-2010. Diab Care 2010, 33 (Suppl 1):S11-61.
-
(2010)
Diab Care
, vol.33
, Issue.SUPPL. 1
-
-
-
9
-
-
0035433201
-
Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy
-
Singleton JR, Smith AG, Bromberg MB: Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diab Care 2001, 24:1448-1453. (Pubitemid 33716436)
-
(2001)
Diabetes Care
, vol.24
, Issue.8
, pp. 1448-1453
-
-
Singleton, J.R.1
Smith, A.G.2
Bromberg, M.B.3
-
10
-
-
33746463580
-
Lifestyle intervention for pre-diabetic neuropathy
-
DOI 10.2337/dc06-0224
-
Smith AG, Russell J, Feldman EL, et al.: Lifestyle intervention for pre-diabetic neuropathy. Diab Care 2006, 29:1294-1299. (Pubitemid 44125925)
-
(2006)
Diabetes Care
, vol.29
, Issue.6
, pp. 1294-1299
-
-
Smith, A.G.1
Russell, J.2
Feldman, E.L.3
Goldstein, J.4
Peltier, A.5
Smith, S.6
Hamwi, J.7
Pollari, D.8
Bixby, B.9
Howard, J.10
Singleton, J.R.11
-
11
-
-
4644299727
-
Metabolic issues in the antihypertensive and lipid-lowering heart attack trial study
-
Punzi HA, Punzi CF: Antihypertensive and lipid-lowering heart attack trial study, trinity hypertension research institute: metabolic issues in the antihypertensive and lipid-lowering heart attack trial study. Curr Hypertens Rep 2004, 6:106-110. (Pubitemid 39359550)
-
(2004)
Current Hypertension Reports
, vol.6
, Issue.2
, pp. 106-110
-
-
Punzi, H.A.1
Punzi, C.F.2
-
12
-
-
77951453096
-
Effect of valsartan on the incidence of diabetes and cardiovascular events
-
NAVIGATOR Study Group
-
NAVIGATOR Study Group, McMurray JJ, Holman RR, et al.: Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 2010, 362:1477-1490.
-
(2010)
N Engl J Med
, vol.362
, pp. 1477-1490
-
-
McMurray, J.J.1
Holman, R.R.2
-
13
-
-
0032570130
-
Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: Randomised double-blind controlled trial
-
DOI 10.1016/S0140-6736(98)02478-7
-
Malik RA, Williamson S, Abbott C, et al.: Effect of angiotensin- converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet 1998, 352:1978-1981. (Pubitemid 29000865)
-
(1998)
Lancet
, vol.352
, Issue.9145
, pp. 1978-1981
-
-
Malik, R.A.1
Williamson, S.2
Abbott, C.3
Carrington, A.L.4
Iqbal, J.5
Schady, W.6
Boulton, A.J.M.7
-
14
-
-
78651113487
-
Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats
-
Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Dake B, Yorek MA: Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats. Eur J Pharmacol 2011, 650:556-62.
-
(2011)
Eur J Pharmacol
, vol.650
, pp. 556-562
-
-
Oltman, C.L.1
Davidson, E.P.2
Coppey, L.J.3
Kleinschmidt, T.L.4
Dake, B.5
Yorek, M.A.6
-
15
-
-
0028900386
-
The effect of intensive diabetes therapy on the development and progression of neuropathy
-
the diabetes control and complications trial research group
-
The effect of intensive diabetes therapy on the development and progression of neuropathy. the diabetes control and complications trial research group. Ann Intern Med 1995, 122:561-568.
-
(1995)
Ann Intern Med
, vol.122
, pp. 561-568
-
-
-
16
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
UK prospective diabetes study (UKPDS) group
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK prospective diabetes study (UKPDS) group. Lancet 1998, 352:837-853.
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
17
-
-
0033055724
-
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study
-
DOI 10.1016/S0140-6736(98)07368-1
-
Gaede P, Vedel P, Parving HH, Pedersen O: Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the steno type 2 randomised study. Lancet 1999, 353:617-622. (Pubitemid 29087981)
-
(1999)
Lancet
, vol.353
, Issue.9153
, pp. 617-622
-
-
Gaede, P.1
Vedel, P.2
Parving, H.-H.3
Pedersen, O.4
-
18
-
-
77954966171
-
Effect of prior intensive insulin treatment during the diabetes control and complications trial (DCCT) on peripheral neuropathy in type 1 diabetes during the epidemiology of diabetes interventions and complications (EDIC) study
-
Albers JW, Herman WH, Pop-Busui R, et al.: Effect of prior intensive insulin treatment during the diabetes control and complications trial (DCCT) on peripheral neuropathy in type 1 diabetes during the epidemiology of diabetes interventions and complications (EDIC) study. Diab Care 2010, 33:1090-1096.
-
(2010)
Diab Care
, vol.33
, pp. 1090-1096
-
-
Albers, J.W.1
Herman, W.H.2
Pop-Busui, R.3
-
19
-
-
67649497933
-
Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: The diabetes control and complications Trial/Epidemiology of diabetes interventions and complications study (DCCT/EDIC)
-
Pop-Busui R, Low PA, Waberski BH, et al.: Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the diabetes control and complications Trial/Epidemiology of diabetes interventions and complications study (DCCT/EDIC). Circulation 2009, 119:2886-2893.
-
(2009)
Circulation
, vol.119
, pp. 2886-2893
-
-
Pop-Busui, R.1
Low, P.A.2
Waberski, B.H.3
-
20
-
-
0037034257
-
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
-
DOI 10.1056/NEJMoa012512
-
Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403. (Pubitemid 34437694)
-
(2002)
New England Journal of Medicine
, vol.346
, Issue.6
, pp. 393-403
-
-
Knowler, W.C.1
Barrett-Connor, E.2
Fowler, S.E.3
Hamman, R.F.4
Lachin, J.M.5
Walker, E.A.6
Nathan, D.M.7
-
21
-
-
43449136809
-
Impaired glucose regulation and neuropathy
-
By Gilman S. San Diego: Elsevier
-
Russell JW, Smith AG, Singleton JR: Impaired glucose regulation and neuropathy. In Neurobiology of disease. By Gilman S. San Diego: Elsevier; 2006:849-869.
-
(2006)
Neurobiology of Disease
, pp. 849-869
-
-
Russell, J.W.1
Smith, A.G.2
Singleton, J.R.3
-
22
-
-
0345707525
-
Microvascular Complications of Impaired Glucose Tolerance
-
DOI 10.2337/diabetes.52.12.2867
-
Singleton JR, Smith AG, Russell JW, Feldman EL: Microvascular complications of impaired glucose tolerance. Diabetes 2003, 52:2867-2873. (Pubitemid 37466854)
-
(2003)
Diabetes
, vol.52
, Issue.12
, pp. 2867-2873
-
-
Singleton, J.R.1
Smith, A.G.2
Russell, J.W.3
Feldman, E.L.4
-
23
-
-
0032881613
-
Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): A two year multicenter randomized double-blind placebo-controlled trial (ALADIN II)
-
DOI 10.1080/10715769900300721
-
Reljanovic M, Reichel G, Rett K, et al.: Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a 2 year multicenter randomized double-blind placebo-controlled trial (ALADIN II). alpha lipoic acid in diabetic neuropathy. Free Radic Res 1999, 31:171-179. (Pubitemid 29435878)
-
(1999)
Free Radical Research
, vol.31
, Issue.3
, pp. 171-179
-
-
Reljanovic, M.1
Reichel, G.2
Rett, K.3
Lobisch, M.4
Schuette, K.5
Moller, W.6
Tritschler, H.-J.7
Mehnert, H.8
-
24
-
-
0032788081
-
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A 7-month multicenter randomized controlled trial (ALADIN III study)
-
DOI 10.2337/diacare.22.8.1296
-
Ziegler D, Hanefeld M, Ruhnau KJ, et al.: Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III study). ALADIN III study group. alphalipoic acid in diabetic neuropathy. Diab Care 1999, 22:1296-1301. (Pubitemid 29350240)
-
(1999)
Diabetes Care
, vol.22
, Issue.8
, pp. 1296-1301
-
-
Ziegler, D.1
Hanefeld, M.2
Ruhnau, K.-J.3
Hasche, H.4
Lobisch, M.5
Schutte, K.6
Kerum, G.7
Malessa, R.8
-
25
-
-
0031028636
-
Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN study). Deutsche kardiale autonome neuropathie
-
Ziegler D, Schatz H, Conrad F, Gries FA, Ulrich H, Reichel G: Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN study). Deutsche kardiale autonome neuropathie. Diab Care 1997, 20:369-373.
-
(1997)
Diab Care
, vol.20
, pp. 369-373
-
-
Ziegler, D.1
Schatz, H.2
Conrad, F.3
Gries, F.A.4
Ulrich, H.5
Reichel, G.6
-
26
-
-
33845499323
-
Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy
-
DOI 10.2337/dc06-1216
-
Ziegler D, Ametov A, Barinov A, et al.: Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diab Care 2006, 29:2365-2370. (Pubitemid 44912237)
-
(2006)
Diabetes Care
, vol.29
, Issue.11
, pp. 2365-2370
-
-
Ziegler, D.1
Ametov, A.2
Barinov, A.3
Dyck, P.J.4
Gurieva, I.5
Low, P.A.6
Munzel, U.7
Yakhno, N.8
Raz, I.9
Novosadova, M.10
Maus, J.11
Samigullin, R.12
-
27
-
-
1242337352
-
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: A meta-analysis
-
DOI 10.1111/j.1464-5491.2004.01109.x
-
Ziegler D, Nowak H, Kempler P, Vargha P, Low PA: Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med 2004, 21:114-121. (Pubitemid 38221809)
-
(2004)
Diabetic Medicine
, vol.21
, Issue.2
, pp. 114-121
-
-
Ziegler, D.1
Nowak, H.2
Kempler, P.3
Vargha, P.4
Low, P.A.5
-
28
-
-
0034883601
-
Painful sensory polyneuropathy associated with impaired glucose tolerance
-
Singleton JR, Smith AG, Bromberg MB: Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve 2001, 24:1225-1228.
-
(2001)
Muscle Nerve
, vol.24
, pp. 1225-1228
-
-
Singleton, J.R.1
Smith, A.G.2
Bromberg, M.B.3
-
29
-
-
75549084221
-
Painful diabetic neuropathy: Advantage of novel drugs over old drugs?
-
This is an excellent review of painful diabetic neuropathy, with a focus on treatment strategies
-
Ziegler D: Painful diabetic neuropathy: advantage of novel drugs over old drugs? Diab Care 2009, 32(Suppl 2):S414-9. This is an excellent review of painful diabetic neuropathy, with a focus on treatment strategies
-
(2009)
Diab Care
, vol.32
, Issue.SUPPL. 2
-
-
Ziegler, D.1
-
30
-
-
75649105067
-
Assessment: Efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review): Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology
-
This is a comprehensive review of the literature showing evidence for use of transcutaneous electrical nerve stimulation in painful neurologic conditions, including painful diabetic neuropathy
-
Dubinsky RM, Miyasaki J: Assessment: efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review): Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 2010, 74:173-176. This is a comprehensive review of the literature showing evidence for use of transcutaneous electrical nerve stimulation in painful neurologic conditions, including painful diabetic neuropathy
-
(2010)
Neurology
, vol.74
, pp. 173-176
-
-
Dubinsky, R.M.1
Miyasaki, J.2
-
31
-
-
0032477294
-
Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. A randomized controlled trial
-
Backonja M, Beydoun A, Edwards KR, et al.: Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998, 280:1831-1836. (Pubitemid 28544423)
-
(1998)
Journal of the American Medical Association
, vol.280
, Issue.21
, pp. 1831-1836
-
-
Backonja, M.1
Beydoun, A.2
Edwards, K.R.3
Schwartz, S.L.4
Fonseca, V.5
Hes, M.6
LaMoreaux, L.7
Garofalo, E.8
-
32
-
-
0032910201
-
Gabapentin in the treatment of painful diabetic neuropathy: A placebo controlled, double blind, crossover trial [4]
-
Gorson KC, Schott C, Herman R, Ropper AH, Rand WM: Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial. J Neurol Neurosurg Psychiatry 1999, 66:251-252. (Pubitemid 29103537)
-
(1999)
Journal of Neurology Neurosurgery and Psychiatry
, vol.66
, Issue.2
, pp. 251-252
-
-
Gorson, K.C.1
Schott, C.2
Herman, R.3
Ropper, A.H.4
Rand, W.M.5
-
33
-
-
10444245040
-
Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial
-
Lesser H, Sharma U, LaMoreaux L, Poole RM: Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 2004, 63:2104-2110. (Pubitemid 39636259)
-
(2004)
Neurology
, vol.63
, Issue.11
, pp. 2104-2110
-
-
Lesser, H.1
Sharma, U.2
LaMoreaux, L.3
Poole, R.M.4
-
34
-
-
3843088696
-
Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial
-
DOI 10.1016/j.pain.2004.05.001, PII S0304395904002465
-
Rosenstock J, Tuchman M, LaMoreaux L, Sharma U: Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 2004, 110:628-638. (Pubitemid 39036794)
-
(2004)
Pain
, vol.110
, Issue.3
, pp. 628-638
-
-
Rosenstock, J.1
Tuchman, M.2
Lamoreaux, L.3
Sharma, U.4
-
35
-
-
16844380945
-
Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial
-
Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE: Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain2005, 6:253-260.
-
(2005)
J Pain
, vol.6
, pp. 253-260
-
-
Richter, R.W.1
Portenoy, R.2
Sharma, U.3
Lamoreaux, L.4
Bockbrader, H.5
Knapp, L.E.6
-
36
-
-
19444362218
-
Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens
-
DOI 10.1016/j.pain.2005.02.032, PII S0304395905001041
-
Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M: Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 2005, 115:254-263. (Pubitemid 40725282)
-
(2005)
Pain
, vol.115
, Issue.3
, pp. 254-263
-
-
Freynhagen, R.1
Strojek, K.2
Griesing, T.3
Whalen, E.4
Balkenohl, M.5
-
37
-
-
0036838156
-
Sodium valproate in the management of painful neuropathy in type 2 diabetes - A randomized placebo controlled study
-
DOI 10.1034/j.1600-0404.2002.01229.x
-
Kochar DK, Jain N, Agarwal RP, Srivastava T, Agarwal P, Gupta S: Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study. Acta Neurol Scand 2002, 106:248-252. (Pubitemid 35177990)
-
(2002)
Acta Neurologica Scandinavica
, vol.106
, Issue.5
, pp. 248-252
-
-
Kochar, D.K.1
Jain, N.2
Agarwal, R.P.3
Srivastava, T.4
Agarwal, P.5
Gupta, S.6
-
38
-
-
1042269461
-
Sodium valproate for painful diabetic neuropathy: A randomized double-blind placebo-controlled study
-
DOI 10.1093/qjmed/hch007
-
Kochar DK, Rawat N, Agrawal RP, et al.: Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. QJM 2004, 97:33-38. (Pubitemid 38195700)
-
(2004)
QJM - Monthly Journal of the Association of Physicians
, vol.97
, Issue.1
, pp. 33-38
-
-
Kochar, D.K.1
Rawat, N.2
Agrawal, R.P.3
Vyas, A.4
Beniwal, R.5
Kochar, S.K.6
Garg, P.7
-
39
-
-
4644369311
-
Topiramate vs placebo in painful diabetic neuropathy: Analgesic and metabolic effects
-
Raskin P, Donofrio PD, Rosenthal NR, et al.: Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 2004, 63:865-873. (Pubitemid 39297649)
-
(2004)
Neurology
, vol.63
, Issue.5
, pp. 865-873
-
-
Raskin, P.1
Donofrio, P.D.2
Rosenthal, N.R.3
Hewitt, D.J.4
Jordan, D.M.5
Xiang, J.6
Vinik, A.I.7
-
40
-
-
3843053823
-
Venlafaxine extended release in the treatment of painful diabetic neuropathy: A double-blind, placebo-controlled study
-
DOI 10.1016/j.pain.2004.05.010, PII S0304395904002647
-
Rowbotham MC, Goli V, Kunz NR, Lei D: Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain 2004, 110:697-706. (Pubitemid 39036802)
-
(2004)
Pain
, vol.110
, Issue.3
, pp. 697-706
-
-
Rowbotham, M.C.1
Goli, V.2
Kunz, N.R.3
Lei, D.4
-
41
-
-
0035204953
-
Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy
-
Simpson DA: Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromuscul Dis 2001, 3:53-62.
-
(2001)
J Clin Neuromuscul Dis
, vol.3
, pp. 53-62
-
-
Simpson, D.A.1
-
42
-
-
28444459170
-
A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain
-
DOI 10.1111/j.1526-4637.2005.00061.x
-
Raskin J, Pritchett YL, Wang F, et al.: A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005, 6:346-356. (Pubitemid 41727332)
-
(2005)
Pain Medicine
, vol.6
, Issue.5
, pp. 346-356
-
-
Raskin, J.1
Pritchett, Y.L.2
Wang, F.3
D'Souza, D.N.4
Waninger, A.L.5
Iyengar, S.6
Wernicke, J.F.7
-
43
-
-
20444464304
-
Duloxetine vs. placebo in patients with painful diabetic neuropathy
-
DOI 10.1016/j.pain.2005.03.029, PII S0304395905001557
-
Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S: Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005, 116:109-118. (Pubitemid 40828506)
-
(2005)
Pain
, vol.116
, Issue.1-2
, pp. 109-118
-
-
Goldstein, D.J.1
Lu, Y.2
Detke, M.J.3
Lee, T.C.4
Iyengar, S.5
-
44
-
-
33750341692
-
A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain
-
DOI 10.1212/01.wnl.0000240225.04000.1a, PII 0000611420061024000021
-
Wernicke JF, Pritchett YL, D'Souza DN, et al.: A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006, 67:1411-1420. (Pubitemid 44632065)
-
(2006)
Neurology
, vol.67
, Issue.8
, pp. 1411-1420
-
-
Wernicke, J.F.1
Pritchett, Y.L.2
D'Souza, D.N.3
Waninger, A.4
Tran, P.5
Iyengar, S.6
Raskin, J.7
-
45
-
-
6244309292
-
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats
-
DOI 10.1124/jpet.104.070656
-
Iyengar S, Webster AA, Hemrick-Luecke SK, Xu JY, Simmons RM: Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J Pharmacol Exp Ther 2004, 311:576-584. (Pubitemid 39391542)
-
(2004)
Journal of Pharmacology and Experimental Therapeutics
, vol.311
, Issue.2
, pp. 576-584
-
-
Iyengar, S.1
Webster, A.A.2
Hemrick-Luecke, S.K.3
Xu, J.Y.4
Simmons, R.M.A.5
-
46
-
-
0031441947
-
A comparison of amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics
-
DOI 10.1097/00002508-199712000-00009
-
Vrethem M, Boivie J, Arnqvist H, Holmgren H, Lindstrom T, Thorell LH: A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics. Clin J Pain 1997, 13:313-323. (Pubitemid 28028096)
-
(1997)
Clinical Journal of Pain
, vol.13
, Issue.4
, pp. 313-323
-
-
Vrethem, M.1
Boivie, J.2
Arnqvist, H.3
Holmgren, H.4
Lindstrom, T.5
Thorell, L.-H.6
-
47
-
-
0023232192
-
Endogenous monoamine analgesic systems: Amitriptyline in painful diabetic neuropathy
-
Max MB: Endogenous monoamine analgesic systems: amitriptyline in painful diabetic neuropathy. Anesth Prog 1987, 34:123-127.
-
(1987)
Anesth Prog
, vol.34
, pp. 123-127
-
-
Max, M.B.1
-
48
-
-
0023155057
-
Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood
-
Max MB, Culnane M, Schafer SC, et al.: Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987, 37:589-596. (Pubitemid 17057933)
-
(1987)
Neurology
, vol.37
, Issue.4
, pp. 589-596
-
-
Max, M.B.1
Culnane, M.2
Schafer, S.C.3
-
49
-
-
0021328357
-
Imipramine treatment of painful diabetic neuropathy
-
DOI 10.1001/jama.251.13.1727
-
Kvinesdal B, Molin J, Froland A, Gram LF: Imipramine treatment of painful diabetic neuropathy. JAMA 1984, 251:1727-1730. (Pubitemid 14174179)
-
(1984)
Journal of the American Medical Association
, vol.251
, Issue.13
, pp. 1727-1730
-
-
Kvinesdal, B.1
Molin, J.2
Froland, A.3
Gram, L.F.4
-
50
-
-
0022352168
-
Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study
-
DOI 10.1016/0304-3959(85)90010-7
-
Gomez-Perez FJ, Rull JA, Dies H, Rodriquez-Rivera JG, Gonzalez-Barranco J, Lozano-Castaneda O: Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study. Pain 1985, 23:395-400. (Pubitemid 16212853)
-
(1985)
Pain
, vol.23
, Issue.4
, pp. 395-400
-
-
Gomez-Perez, F.J.1
Rull, J.A.2
Dies, H.3
-
51
-
-
0032877110
-
Tramadol relieves pain and allodynia in polyneuropathy: A randomised, double-blind, controlled trial
-
DOI 10.1016/S0304-3959(99)00079-2, PII S0304395999000792
-
Sindrup SH, Andersen G, Madsen C, Smith T, Brosen K, Jensen TS: Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial. Pain 1999, 83:85-90. (Pubitemid 29446160)
-
(1999)
Pain
, vol.83
, Issue.1
, pp. 85-90
-
-
Sindrup, S.H.1
Andersen, G.2
Madsen, C.3
Smith, T.4
Brosen, K.5
Jensen, T.S.6
-
52
-
-
0026714873
-
Opioid sensitivity of chronic pain: A patient-controlled analgesia method
-
McQuay HJ, Jadad AR, Carroll D, et al.: Opioid sensitivity of chronic pain: a patient-controlled analgesia method. Anaesthesia 1992, 47:757-767.
-
(1992)
Anaesthesia
, vol.47
, pp. 757-767
-
-
McQuay, H.J.1
Jadad, A.R.2
Carroll, D.3
-
53
-
-
15744389846
-
Morphine, gabapentin, or their combination for neuropathic pain
-
DOI 10.1056/NEJMoa042580
-
Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL: Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005, 352:1324-1334. (Pubitemid 40411499)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.13
, pp. 1324-1334
-
-
Gilron, I.1
Bailey, J.M.2
Tu, D.3
Holden, R.R.4
Weaver, D.F.5
Houlden, R.L.6
-
54
-
-
0031779616
-
Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy
-
Harati Y, Gooch C, Swenson M, et al.: Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998, 50:1842-1846. (Pubitemid 28283262)
-
(1998)
Neurology
, vol.50
, Issue.6
, pp. 1842-1846
-
-
Harati, Y.1
Gooch, C.2
Swenson, M.3
Edelman, S.4
Greene, D.5
Raskin, P.6
Donofrio, P.7
Cornblath, D.8
Sachdeo, R.9
Siu, C.O.10
Kamin, M.11
-
55
-
-
33846698387
-
Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy
-
DOI 10.1185/030079906X162674
-
Freeman R, Raskin P, Hewitt DJ, et al.: Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy. Curr Med Res Opin 2007, 23:147-161. (Pubitemid 46191680)
-
(2007)
Current Medical Research and Opinion
, vol.23
, Issue.1
, pp. 147-161
-
-
Freeman, R.1
Raskin, P.2
Hewitt, D.J.3
Vorsanger, G.J.4
Jordan, D.M.5
Xiang, J.6
Rosenthal, N.R.7
-
56
-
-
0025366543
-
Capsaicin: Actions on nociceptive C-fibres and therapeutic potential
-
Lynn B: Capsaicin: actions on nociceptive C-fibres and therapeutic potential. Pain 1990, 41:61-69.
-
(1990)
Pain
, vol.41
, pp. 61-69
-
-
Lynn, B.1
-
57
-
-
0026500908
-
Topical capsaicin in painful diabetic neuropathy. controlled study with long-term follow-up
-
Tandan R, Lewis GA, Krusinski PB, Badger GB, Fries TJ: Topical capsaicin in painful diabetic neuropathy. controlled study with long-term follow-up. Diab Care 1992, 15:8-14.
-
(1992)
Diab Care
, vol.15
, pp. 8-14
-
-
Tandan, R.1
Lewis, G.A.2
Krusinski, P.B.3
Badger, G.B.4
Fries, T.J.5
-
58
-
-
0025841729
-
Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study
-
the capsaicin study group
-
Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. the capsaicin study group. Arch Intern Med 1991, 151:2225-2229.
-
(1991)
Arch Intern Med
, vol.151
, pp. 2225-2229
-
-
-
59
-
-
13144282687
-
Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: Assessment with the neuropathic pain scale
-
Argoff CE, Galer BS, Jensen MP, Oleka N, Gammaitoni AR: Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the neuropathic pain scale. Curr Med Res Opin 2004, 20(Suppl 2):S21-8.
-
(2004)
Curr Med Res Opin
, vol.20
, Issue.SUPPL. 2
-
-
Argoff, C.E.1
Galer, B.S.2
Jensen, M.P.3
Oleka, N.4
Gammaitoni, A.R.5
-
60
-
-
2942532905
-
Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy
-
DOI 10.1001/archneur.61.6.914
-
Barbano RL, Herrmann DN, Hart-Gouleau S, Pennella-Vaughan J, Lodewick PA, Dworkin RH: Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol 2004, 61:914-918. (Pubitemid 38747332)
-
(2004)
Archives of Neurology
, vol.61
, Issue.6
, pp. 914-918
-
-
Barbano, R.L.1
Herrmann, D.N.2
Hart-Gouleau, S.3
Pennella-Vaughan, J.4
Lodewick, P.A.5
Dworkin, R.H.6
-
61
-
-
0035399658
-
Effect of alpha-lipoic acid on vascular responses and nociception in diabetic rats
-
DOI 10.1016/S0891-5849(01)00564-0, PII S0891584901005640
-
Cameron NE, Jack AM, Cotter MA: Effect of alpha-lipoic acid on vascular responses and nociception in diabetic rats. Free Radic Biol Med 2001, 31:125-135. (Pubitemid 32568432)
-
(2001)
Free Radical Biology and Medicine
, vol.31
, Issue.1
, pp. 125-135
-
-
Cameron, N.E.1
Jack, A.M.2
Cotter, M.A.3
-
62
-
-
0028845524
-
Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN study)
-
Ziegler D, Hanefeld M, Ruhnau KJ, et al.: Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN study). Diabetologia 1995, 38:1425-1433.
-
(1995)
Diabetologia
, vol.38
, pp. 1425-1433
-
-
Ziegler, D.1
Hanefeld, M.2
Ruhnau, K.J.3
|